Noah Berkowitz

CIK 1369900 · Chief Medical Officer · last filed 2026-05-13

Noah Berkowitz is a Chief Medical Officer who has filed 25 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for ARVN, was dated Jul 9, 2026. Across all open-market trades the lifetime net is −$323.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$1.54M

Companies

3

Total Filings

25

Lifetime Open-Market Net

-$323.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ARVN	Chief Medical Officer	191,395	$8.06	$1.54M	-$323.8K	8	2026-05-13
Synvista Therapeutics, Inc. (SYI) Delisted	President & CEO	259,190	—	—	$0	11	2008-12-03
ALT	President & CEO	595	$3.00	$1.8K	$0	1	2007-02-09

Recent Filings

25 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-07-09	ARVN	Notice (144)	−24,000	-$201.5K	EDGAR
2026-05-13	ARVN	Sell (S)	−11,108	-$110.4K	EDGAR
2026-05-08	ARVN	Notice (144)	−11,312	-$114.4K	EDGAR
2026-03-19	ARVN	Sell (S)	−6,435	-$71.4K	EDGAR
2026-03-17	ARVN	Notice (144)	−6,022	-$72.3K	EDGAR
2026-03-02	ARVN	Grant (A)	+45,000	$0	EDGAR
2026-02-18	ARVN	Sell (S)	−5,685	-$67.6K	EDGAR
2026-02-13	ARVN	Notice (144)	−5,685	-$67.6K	EDGAR
2025-05-13	ARVN	Grant (A)	+59,600	$0	EDGAR
2025-03-19	ARVN	Sell (S)	−8,658	-$74.4K	EDGAR

Showing 1–10 of 25

Page 1 of 3 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.